No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

MicroPort Orthopedics Expands Commercial Leadership Team with Global Vice President of Marketing and Professional Education and North America Vice President of Sales

Strategic new hires join medical device company to accelerate US and global commercial operations

Editor: What To Know

  • Brian Collins is joining as Global Vice President of Marketing and Professional Education and Shawn Gabriel as Vice President of Sales, North America.
  • “Brian and Shawn's expertise will equip our commercial leadership team with the tools necessary to continue our strategic growth in the US and beyond,” said Rob Cripe, Chief Commercial Officer of MicroPort Orthopedics.
  • As MicroPort Orthopedics VP of Marketing and Professional Education, Brian is excited to leverage their clinical implant history, paired with upcoming enabling technology launches, to improve surgical guidance for their customers and improve outcomes for their patients.

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, announces today the expansion of its commercial leadership team with two strategic hires: Brian Collins is joining as Global Vice President of Marketing and Professional Education and Shawn Gabriel as Vice President of Sales, North America. Both Brian and Shawn have extensive experience in sales and marketing for medical devices.

Brian Collins brings more than 12 years of experience in the medical device industry-leading strategy and execution to the MicroPort Orthopedics team. In his most recent role as Global Vice President of Marketing and Medical Education for ZimVie, he guided the successful spin-off from Zimmer Biomet. Prior to ZimVie, Brian held various roles in Sales, National Accounts, and Marketing for companies such as Stryker, Depuy Synthes, and Zimmer Biomet. As MicroPort Orthopedics VP of Marketing and Professional Education, Brian is excited to leverage their clinical implant history, paired with upcoming enabling technology launches, to improve surgical guidance for their customers and improve outcomes for their patients.

Shawn Gabriel has over 20 years of experience in the medical device industry leading sales teams and exceeding performance goals. Shawn has worked for Johnson & Johnson, Smith & Nephew, Medtronic, Tornier, and HillRom. During the various roles held at these companies, he has continuously demonstrated excellence in revenue growth, sales team effectiveness, and solution selling of medical devices. He has experience in leading sales teams within an independent distribution network, as well as direct sales. In his previous roles, Shawn has consistently fostered cultures aligned with company values and focused on delivering performance as a cohesive unit. As MicroPort Orthopedics VP of Sales for North America, Shawn will bring his experience and leadership to align and exceed sales goals.

“Brian and Shawn’s expertise will equip our commercial leadership team with the tools necessary to continue our strategic growth in the US and beyond,” said Rob Cripe, Chief Commercial Officer of MicroPort Orthopedics. “These additions to our team are another way that MicroPort is prioritizing advancing itself as a leader in the medical device industry.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy